Literature DB >> 16422006

Borrelia spielmanii erythema migrans, Hungary.

Gábor Földvári, Róbert Farkas, András Lakos.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16422006      PMCID: PMC3367353          DOI: 10.3201/eid1111.050542

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Lyme disease is the most frequent tickborne human infection in the northern hemisphere. At least 5 species of the Borrelia burgdorferi sensu lato complex, B. burgdorferi sensu stricto, B. afzelii, B. garinii, B. bissettii, and B. lusitaniae, have a pathogenic role in human Lyme disease in central Europe (–). A sixth pathogenic strain, A14S, has been isolated from 1 Dutch () and 2 German patients with erythema migrans (). This strain was also detected in 4 questing Ixodes ricinus ticks in Germany (,) and 1 in the Czech Republic (). A14S has recently been described as a new species, B. spielmanii (); its main reservoir host is probably the garden dormouse (Eliomys quercinus), but B. spielmanii could not be detected in mice or voles. Richter et al. () could not find ticks harboring B. spielmanii in 3 of 5 examined areas in Germany. They were present almost exclusively in a single area where the prevalence of infection with this genotype was 15 (6%) of 251. We describe the isolation of this novel Lyme disease spirochete from a human patient with erythema migrans in Hungary. Since 1999, we have regularly isolated Borrelia burgdorferi sensu lato from skin biopsy specimens of erythema migrans and acrodermatitis chronica atrophicans taken from patients at the Center for Tick-borne Diseases, Budapest, Hungary. To identify the Borrelia species occurring in Hungarian Lyme disease patients, we have started to molecularly analyze cultured isolates that originate from erythema migrans of different patients. DNA was isolated from 8 bacterial pellets by using QIAamp DNA mini kit (Qiagen, Hilden, Germany). Primers BSL-F and BSL-R were used; these amplify an ≈250-bp region of the outer surface protein (osp) A gene from all Lyme disease spirochetes (). We added 2 μL extracted DNA to a 20-μL reaction mixture composed of 1.0 U HotStartTaq DNA polymerase, 200 μmol/L of each dNTP, 25 pmol of each primer, and 1.5 mmol/L MgCl2 (HotStartTaq Master Mix, Qiagen). An initial denaturation step at 94°C for 15 min was followed by 40 cycles of denaturation at 94°C for 30 s, annealing at 58°C for 30 s, and extension at 72°C for 30 s. Final extension was done at 72°C for 5 min. Amplified DNA was subjected to electrophoresis in a 1.5% agarose gel that was prestained with ethidium bromide and viewed under UV light. After purification, the dideoxy chain termination (Applied Biosystems Division, Foster City, CA, USA) was used for sequencing. Obtained sequences were checked with Chromas v.1.45 and compared to sequence data available from GenBank by using BLAST (http://www.ncbi.nlm.nih.gov/BLAST/). New sequences were submitted to GenBank. Six sequences (DQ007298, DQ007299, DQ007300, DQ007301, DQ007302, DQ007303) showed 100% homology to B. afzelii Khab 625 strain (AY502599). One (DQ007297) of the remaining 2 samples showed 99.6% similarity with B. burgdorferi B31 (AE000790), and the other (AY995900) showed 99.21% similarity with B. spielmanii (AF102057). The patient whose culture showed B. spielmanii was a 42-year-old woman with a homogenous erythema migrans, diagnosed on September 24, 1999. The erythema was 10 cm in diameter on the front surface of the knee at the first visit (Figure). The immunoglobulin M (IgM) and IgG Borrelia immunoblot that applied B. afzelii (ACA1) antigen was negative in serum drawn on the seventh day after the appearance of erythema migrans. The patient did not remember a tick bite and had not traveled abroad during the previous 6 months. She complained of an "extremely unusual," intense, serous nasal discharge that started 3 weeks before the appearance of erythema migrans and of a moderate headache; both disappeared spontaneously 2 weeks before treatment.
Figure

Erythema migrans caused by Borrelia spielmanii.

Erythema migrans caused by Borrelia spielmanii. Our results show at least 3 distinct species of B. burgdorferi sensu lato in Hungary. In addition to B. burgdorferi sensu stricto and B. afzelii, known throughout Europe, we detected the recently described species B. spielmanii among randomly selected samples. Together with 2 previous publications (,), our observation also suggest that B. spielmanii has a pathogenic role in human Lyme disease. Although B. spielmanii is distributed more focally than other species of the B. burgdorferi sensu lato complex (), it occurs from the Netherlands through Germany and Czech Republic to Hungary (,,,).
  9 in total

1.  Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with lyme borreliosis.

Authors:  G Wang; A P van Dam; J Dankert
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Solitary borrelial lymphocytoma in adult patients.

Authors:  Vera Maraspin; Joze Cimperman; Stanka Lotric-Furlan; Eva Ruzić-Sabljić; Tomaz Jurca; Roger N Picken; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2002-07-31       Impact factor: 1.704

3.  Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe.

Authors:  Dania Richter; Daniela B Schlee; Rainer Allgöwer; Franz-Rainer Matuschka
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

4.  Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR.

Authors:  Carolin Rauter; Rainer Oehme; Isabel Diterich; Matthias Engele; Thomas Hartung
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

5.  First isolation of Borrelia lusitaniae from a human patient.

Authors:  M Collares-Pereira; S Couceiro; I Franca; K Kurtenbach; S M Schäfer; L Vitorino; L Gonçalves; S Baptista; M L Vieira; C Cunha
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types.

Authors:  H Michel; B Wilske; G Hettche; G Göttner; C Heimerl; U Reischl; U Schulte-Spechtel; V Fingerle
Journal:  Med Microbiol Immunol       Date:  2003-09-12       Impact factor: 3.402

7.  Genetic variability within Borrelia burgdorferi sensu lato genospecies established by PCR-single-strand conformation polymorphism analysis of the rrfA-rrlB intergenic spacer in ixodes ricinus ticks from the Czech Republic.

Authors:  Markéta Derdáková; Lorenza Beati; Branislav Pet'ko; Michal Stanko; Durland Fish
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

8.  Expanded diversity among Californian borrelia isolates and description of Borrelia bissettii sp. nov. (formerly Borrelia group DN127).

Authors:  D Postic; N M Ras; R S Lane; M Hendson; G Baranton
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

9.  Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients.

Authors:  I Demaerschalck; A Ben Messaoud; M De Kesel; B Hoyois; Y Lobet; P Hoet; G Bigaignon; A Bollen; E Godfroid
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

  9 in total
  18 in total

Review 1.  A Review of the Centers for Disease Control and Prevention's Guidelines for the Clinical Laboratory Diagnosis of Lyme Disease.

Authors:  Caterina M Miraglia
Journal:  J Chiropr Med       Date:  2016-10-05

2.  Prevalence and seasonality of tick-borne pathogens in questing Ixodes ricinus ticks from Luxembourg.

Authors:  Anna L Reye; Judith M Hübschen; Aurélie Sausy; Claude P Muller
Journal:  Appl Environ Microbiol       Date:  2010-03-12       Impact factor: 4.792

3.  Reservoir competence of various rodents for the lyme disease Spirochete Borrelia spielmanii.

Authors:  Dania Richter; Daniela B Schlee; Franz-Rainer Matuschka
Journal:  Appl Environ Microbiol       Date:  2011-04-01       Impact factor: 4.792

4.  In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.

Authors:  Kristina Morgenstern; Georg Baljer; Douglas E Norris; Peter Kraiczy; Christa Hanssen-Hübner; Klaus-Peter Hunfeld
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

5.  Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.

Authors:  Corinna Siegel; Teresia Hallström; Christine Skerka; Hannes Eberhardt; Barbara Uzonyi; Tobias Beckhaus; Michael Karas; Reinhard Wallich; Brian Stevenson; Peter F Zipfel; Peter Kraiczy
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

6.  Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.

Authors:  Claudia Hammerschmidt; Arno Koenigs; Corinna Siegel; Teresia Hallström; Christine Skerka; Reinhard Wallich; Peter F Zipfel; Peter Kraiczy
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

Review 7.  Emerging zoonoses and vector-borne infections affecting humans in Europe.

Authors:  R M Vorou; V G Papavassiliou; S Tsiodras
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

8.  Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum, Francisella tularensis and their co-infections in host-seeking Ixodes ricinus ticks collected in Serbia.

Authors:  Marija Milutinović; Toshiyuki Masuzawa; Snezana Tomanović; Zeljko Radulović; Takashi Fukui; Yoshihiro Okamoto
Journal:  Exp Appl Acarol       Date:  2008-06-13       Impact factor: 2.132

9.  Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1.

Authors:  Pia Herzberger; Corinna Siegel; Christine Skerka; Volker Fingerle; Ulrike Schulte-Spechtel; Alje van Dam; Bettina Wilske; Volker Brade; Peter F Zipfel; Reinhard Wallich; Peter Kraiczy
Journal:  Infect Immun       Date:  2007-07-16       Impact factor: 3.441

10.  First report of Anaplasma phagocytophilum and its co-infections with Borrelia burgdorferi sensu lato in Ixodes ricinus ticks (Acari: Ixodidae) from Republic of Moldova.

Authors:  Juraj Koci; Alexandru Movila; Veronika Taragel'ová; Ion Toderas; Inga Uspenskaia; Markéta Derdáková; Milan Labuda
Journal:  Exp Appl Acarol       Date:  2007-03-07       Impact factor: 2.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.